Cargando…
Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study
BACKGROUND: Cardio-vascular disease and depression are thought to be closely related, due to shared risk factors. The aim of the study was to determine the association between cardio-vascular risk (CVR) factors and depressive status in a population (55–75 years) with metabolic syndrome (MetS) from t...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007355/ https://www.ncbi.nlm.nih.gov/pubmed/35417452 http://dx.doi.org/10.1371/journal.pone.0265079 |
_version_ | 1784686829590544384 |
---|---|
author | Martín-Peláez, Sandra Serra-Majem, Lluis Cano-Ibáñez, Naomi Martínez-González, Miguel Ángel Salas-Salvadó, Jordi Corella, Dolores Lassale, Camille Martínez, Jose Alfredo Alonso-Gómez, Ángel M. Wärnberg, Julia Vioque, Jesús Romaguera, Dora López-Miranda, José Estruch, Ramón Tinahones, Francisco J. Lapetra, José Fernández-Aranda, Fernando Bueno-Cavanillas, Aurora Tur, Josep A. Martín, Vicente Pintó, Xavier Delgado-Rodríguez, Miguel Matía, Pilar Vidal, Josep Vázquez, Clotilde Daimiel, Lidia Ros, Emili Toledo, Estefanía Nishi, Stephanie K. Sorli, Jose V. Malcampo, Mireia Zulet, M. Ángeles Moreno-Rodríguez, Anaí Cueto-Galán, Raquel Vivancos-Aparicio, Diego Colom, Antoni García-Ríos, Antonio Casas, Rosa Bernal-López, M Rosa Santos-Lozano, Jose Manuel Vázquez, Zenaida Gómez-Martínez, Carlos Ortega-Azorín, Carolina del Val, Jose Luís Abete, Itziar Goikoetxea-Bahon, Amaia Pascual, Elena Becerra-Tomás, Nerea Chillarón, Juan J. Sánchez-Villegas, Almudena |
author_facet | Martín-Peláez, Sandra Serra-Majem, Lluis Cano-Ibáñez, Naomi Martínez-González, Miguel Ángel Salas-Salvadó, Jordi Corella, Dolores Lassale, Camille Martínez, Jose Alfredo Alonso-Gómez, Ángel M. Wärnberg, Julia Vioque, Jesús Romaguera, Dora López-Miranda, José Estruch, Ramón Tinahones, Francisco J. Lapetra, José Fernández-Aranda, Fernando Bueno-Cavanillas, Aurora Tur, Josep A. Martín, Vicente Pintó, Xavier Delgado-Rodríguez, Miguel Matía, Pilar Vidal, Josep Vázquez, Clotilde Daimiel, Lidia Ros, Emili Toledo, Estefanía Nishi, Stephanie K. Sorli, Jose V. Malcampo, Mireia Zulet, M. Ángeles Moreno-Rodríguez, Anaí Cueto-Galán, Raquel Vivancos-Aparicio, Diego Colom, Antoni García-Ríos, Antonio Casas, Rosa Bernal-López, M Rosa Santos-Lozano, Jose Manuel Vázquez, Zenaida Gómez-Martínez, Carlos Ortega-Azorín, Carolina del Val, Jose Luís Abete, Itziar Goikoetxea-Bahon, Amaia Pascual, Elena Becerra-Tomás, Nerea Chillarón, Juan J. Sánchez-Villegas, Almudena |
author_sort | Martín-Peláez, Sandra |
collection | PubMed |
description | BACKGROUND: Cardio-vascular disease and depression are thought to be closely related, due to shared risk factors. The aim of the study was to determine the association between cardio-vascular risk (CVR) factors and depressive status in a population (55–75 years) with metabolic syndrome (MetS) from the PREDIMED-Plus trial. METHODS AND FINDINGS: Participants were classified into three groups of CVR according to the Framingham-based REGICOR function: (1) low (LR), (2) medium (MR) or (3) high/very high (HR). The Beck Depression Inventory-II (BDI-II) was used to assess depressive symptoms at baseline and after 2 years. The association between CVR and depressive status at baseline (n = 6545), and their changes after 2 years (n = 4566) were evaluated through multivariable regression models (logistic and linear models). HR women showed higher odds of depressive status than LR [OR (95% CI) = 1.78 (1.26, 2.50)]. MR and HR participants with total cholesterol <160 mg/mL showed higher odds of depression than LR [OR (95% CI) = 1.77 (1.13, 2.77) and 2.83 (1.25, 6.42) respectively)] but those with total cholesterol ≥280 mg/mL showed lower odds of depression than LR [OR (95% CI) = 0.26 (0.07, 0.98) and 0.23 (0.05, 0.95), respectively]. All participants decreased their BDI-II score after 2 years, being the decrease smaller in MR and HR diabetic compared to LR [adjusted mean±SE = -0.52±0.20, -0.41±0.27 and -1.25±0.31 respectively). MR and HR participants with total cholesterol between 240–279 mg/mL showed greater decreases in the BDI-II score compared to LR (adjusted mean±SE = -0.83±0.37, -0.77±0.64 and 0.97±0.52 respectively). CONCLUSIONS: Improving cardiovascular health could prevent the onset of depression in the elderly. Diabetes and total cholesterol in individuals at high CVR, may play a specific role in the precise response. International Standard Randomized Controlled Trial (ISRCTN89898870). |
format | Online Article Text |
id | pubmed-9007355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-90073552022-04-14 Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study Martín-Peláez, Sandra Serra-Majem, Lluis Cano-Ibáñez, Naomi Martínez-González, Miguel Ángel Salas-Salvadó, Jordi Corella, Dolores Lassale, Camille Martínez, Jose Alfredo Alonso-Gómez, Ángel M. Wärnberg, Julia Vioque, Jesús Romaguera, Dora López-Miranda, José Estruch, Ramón Tinahones, Francisco J. Lapetra, José Fernández-Aranda, Fernando Bueno-Cavanillas, Aurora Tur, Josep A. Martín, Vicente Pintó, Xavier Delgado-Rodríguez, Miguel Matía, Pilar Vidal, Josep Vázquez, Clotilde Daimiel, Lidia Ros, Emili Toledo, Estefanía Nishi, Stephanie K. Sorli, Jose V. Malcampo, Mireia Zulet, M. Ángeles Moreno-Rodríguez, Anaí Cueto-Galán, Raquel Vivancos-Aparicio, Diego Colom, Antoni García-Ríos, Antonio Casas, Rosa Bernal-López, M Rosa Santos-Lozano, Jose Manuel Vázquez, Zenaida Gómez-Martínez, Carlos Ortega-Azorín, Carolina del Val, Jose Luís Abete, Itziar Goikoetxea-Bahon, Amaia Pascual, Elena Becerra-Tomás, Nerea Chillarón, Juan J. Sánchez-Villegas, Almudena PLoS One Research Article BACKGROUND: Cardio-vascular disease and depression are thought to be closely related, due to shared risk factors. The aim of the study was to determine the association between cardio-vascular risk (CVR) factors and depressive status in a population (55–75 years) with metabolic syndrome (MetS) from the PREDIMED-Plus trial. METHODS AND FINDINGS: Participants were classified into three groups of CVR according to the Framingham-based REGICOR function: (1) low (LR), (2) medium (MR) or (3) high/very high (HR). The Beck Depression Inventory-II (BDI-II) was used to assess depressive symptoms at baseline and after 2 years. The association between CVR and depressive status at baseline (n = 6545), and their changes after 2 years (n = 4566) were evaluated through multivariable regression models (logistic and linear models). HR women showed higher odds of depressive status than LR [OR (95% CI) = 1.78 (1.26, 2.50)]. MR and HR participants with total cholesterol <160 mg/mL showed higher odds of depression than LR [OR (95% CI) = 1.77 (1.13, 2.77) and 2.83 (1.25, 6.42) respectively)] but those with total cholesterol ≥280 mg/mL showed lower odds of depression than LR [OR (95% CI) = 0.26 (0.07, 0.98) and 0.23 (0.05, 0.95), respectively]. All participants decreased their BDI-II score after 2 years, being the decrease smaller in MR and HR diabetic compared to LR [adjusted mean±SE = -0.52±0.20, -0.41±0.27 and -1.25±0.31 respectively). MR and HR participants with total cholesterol between 240–279 mg/mL showed greater decreases in the BDI-II score compared to LR (adjusted mean±SE = -0.83±0.37, -0.77±0.64 and 0.97±0.52 respectively). CONCLUSIONS: Improving cardiovascular health could prevent the onset of depression in the elderly. Diabetes and total cholesterol in individuals at high CVR, may play a specific role in the precise response. International Standard Randomized Controlled Trial (ISRCTN89898870). Public Library of Science 2022-04-13 /pmc/articles/PMC9007355/ /pubmed/35417452 http://dx.doi.org/10.1371/journal.pone.0265079 Text en © 2022 Martín-Peláez et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Martín-Peláez, Sandra Serra-Majem, Lluis Cano-Ibáñez, Naomi Martínez-González, Miguel Ángel Salas-Salvadó, Jordi Corella, Dolores Lassale, Camille Martínez, Jose Alfredo Alonso-Gómez, Ángel M. Wärnberg, Julia Vioque, Jesús Romaguera, Dora López-Miranda, José Estruch, Ramón Tinahones, Francisco J. Lapetra, José Fernández-Aranda, Fernando Bueno-Cavanillas, Aurora Tur, Josep A. Martín, Vicente Pintó, Xavier Delgado-Rodríguez, Miguel Matía, Pilar Vidal, Josep Vázquez, Clotilde Daimiel, Lidia Ros, Emili Toledo, Estefanía Nishi, Stephanie K. Sorli, Jose V. Malcampo, Mireia Zulet, M. Ángeles Moreno-Rodríguez, Anaí Cueto-Galán, Raquel Vivancos-Aparicio, Diego Colom, Antoni García-Ríos, Antonio Casas, Rosa Bernal-López, M Rosa Santos-Lozano, Jose Manuel Vázquez, Zenaida Gómez-Martínez, Carlos Ortega-Azorín, Carolina del Val, Jose Luís Abete, Itziar Goikoetxea-Bahon, Amaia Pascual, Elena Becerra-Tomás, Nerea Chillarón, Juan J. Sánchez-Villegas, Almudena Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study |
title | Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study |
title_full | Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study |
title_fullStr | Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study |
title_full_unstemmed | Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study |
title_short | Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study |
title_sort | contribution of cardio-vascular risk factors to depressive status in the predimed-plus trial. a cross-sectional and a 2-year longitudinal study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007355/ https://www.ncbi.nlm.nih.gov/pubmed/35417452 http://dx.doi.org/10.1371/journal.pone.0265079 |
work_keys_str_mv | AT martinpelaezsandra contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT serramajemlluis contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT canoibaneznaomi contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT martinezgonzalezmiguelangel contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT salassalvadojordi contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT corelladolores contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT lassalecamille contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT martinezjosealfredo contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT alonsogomezangelm contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT warnbergjulia contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT vioquejesus contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT romagueradora contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT lopezmirandajose contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT estruchramon contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT tinahonesfranciscoj contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT lapetrajose contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT fernandezarandafernando contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT buenocavanillasaurora contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT turjosepa contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT martinvicente contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT pintoxavier contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT delgadorodriguezmiguel contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT matiapilar contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT vidaljosep contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT vazquezclotilde contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT daimiellidia contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT rosemili contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT toledoestefania contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT nishistephaniek contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT sorlijosev contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT malcampomireia contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT zuletmangeles contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT morenorodriguezanai contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT cuetogalanraquel contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT vivancosapariciodiego contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT colomantoni contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT garciariosantonio contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT casasrosa contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT bernallopezmrosa contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT santoslozanojosemanuel contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT vazquezzenaida contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT gomezmartinezcarlos contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT ortegaazorincarolina contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT delvaljoseluis contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT abeteitziar contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT goikoetxeabahonamaia contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT pascualelena contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT becerratomasnerea contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT chillaronjuanj contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy AT sanchezvillegasalmudena contributionofcardiovascularriskfactorstodepressivestatusinthepredimedplustrialacrosssectionalanda2yearlongitudinalstudy |